Edit |   |
---|---|
Product Name | SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant) |
Description | Purity > 90% (SDS-PAGE). C-terminal His tag. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits th. Observed MW: 35 kDa |
Size | 50 µg, 100 µg |
Concentration | n/a |
Applications | n/a |
Other Names | Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2; COVID-19; 2019-nCoV; 2019 novel coronavirus; COVID19; SARS-CoV-2 Spike S1 (RBD); SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein; SARS-CoV-2 Spike Protein RBD (India B.1.617.2.1 Variant); SARS-CoV-2 Spike Protein RBD (B.1.617.2.1 India Variant); SARS-CoV-2 Spike Protein RBD (B.1.617.2.1 Indian Variant); SARS-CoV-2 S1 Protein RBD K417N, L452R and T478K Mutations; SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant); SARS-CoV-2 Spike Protein RBD (Delta Plus Variant); SARS-CoV-2 Spike Protein RBD (India AY.1 Variant); SARS-CoV-2 Spike Protein RBD (AY.1 India Variant); SARS-CoV-2 Spike Protein RBD (Delta Plus AY.1 Variant); SARS-CoV-2 Spike Protein RBD (AY.1 Variant) |
Gene, Accession, CAS # | NCBI: YP_009724390.1 |
Catalog # | abx620018 |
Price | please inquire |
Order / More Info | SARS-CoV-2 Spike Protein RBD (Delta Plus B.1.617.2.1 Variant) from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950